Investors / United States / Mountain Group Partners
Mountain Group Partners
Venture capital · Nashville, TN, United States · North America
Mountain Group Partners is a Nashville-based venture capital firm that invests in life sciences and disruptive technologies. It takes an active, long-term approach to investing, drawing on its partners' operating experience and its family office roots.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsdiagnosticsanimal healthhealthcarerenewable energybusiness servicesprecision medicine
Your fit with Mountain Group Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMountain Group Partners lists 30 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (54%), AI & Machine Learning (31%) and Education (6%). 100% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, Blue Venture Funds and RA Capital.
No funding round on record names Mountain Group Partners yet, so the figures come from its portfolio page.
Round figures show recent activity, not Mountain Group Partners' whole history. Rounds on record name 0 companies; its own site lists 30. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 68th | 30 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 86th | 54% in its largest sector |
| Reach | 20th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2790%
- No longer answers00%
- Points to another company310%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 54% | 15% |
| AI & Machine Learning | 31% | 18% |
| Education | 6% | 7% |
| Industrial & Manufacturing | 3% | 7% |
| Fintech | 3% | 12% |
| E-commerce & Marketplaces | 3% | 6% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Mountain Group Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
30 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| 5Metis is a novel mode of action and intellectual property development company solving fungicide resistance for growers worldwide by providing scientific research in the field of agriculture. | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Portfolio page | ||||
| AN2 Therapeutics develops boron-based medicines for various diseases, including polycythemia vera, Chagas disease, and certain types of cancer. | Healthcare & Biotech | Portfolio page | ||
| Appello Pharmaceuticals is working to develop new drugs to improve the lives of patients suffering from neurologic disease. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Castle Biosciences develops and provides molecular prognostic and diagnostic tests for various diseases, including skin and eye cancers. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Circular Genomics develops and provides circular RNA diagnostics and research tools for brain health and neurological diseases | Healthcare & Biotech | Page + round | ||
| Clearside Biomedical, Inc. is an intellectual property holding, investment, and commercialization company with a portfolio of intellectual property covering its proprietary ocular drug-delivery platform and microinjector technology. | Healthcare & Biotech | Portfolio page | ||
| Contego Medical develops and manufactures medical devices for carotid and peripheral vascular procedures. | Healthcare & Biotech | Portfolio page | ||
| The company is focused on modulating cortisol activity to develop novel treatments for severe disorders. | Healthcare & Biotech | Portfolio page | ||
| Ethos provides AI-powered visibility into workforce capability and offers solutions for various industries including defense, life sciences, and industrial sectors. | AI & Machine LearningEducation | Portfolio page | ||
| Portfolio page | ||||
| G1 Therapeutics develops and delivers next generation therapies to improve the lives and outcomes of people living with cancer. | Healthcare & Biotech | Portfolio page | ||
| In The Bowl Animal Health utilizes proprietary technology to deliver prescription medicines and functional OTC feed ingredients through pet food. | Healthcare & Biotech | Portfolio page | ||
| Ironwood Pharmaceuticals is a gastrointestinal healthcare company that advances the treatment of GI diseases | Healthcare & Biotech | Portfolio page | ||
| The company provides genetic testing and counseling services | Healthcare & Biotech | Portfolio page | ||
| Mindera Health captures thousands of RNA transcripts to provide actionable data-driven decisions for patients, providers, and payers | Healthcare & Biotech | Page + round | ||
| NuSirt Sciences combines established pharmaceuticals and natural products to activate the sirtuin pathway, thereby addressing conditions associated with aging and overnutrition. | Healthcare & Biotech | Portfolio page | ||
| The company is developing specialized therapies to treat cardiovascular diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mtngp.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 30
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Mountain Group Partners' profile as data
Pull Mountain Group Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mtngp.com
# also
GET /v1/firms/mtngp.com/portfolio
GET /v1/firms/mtngp.com/coinvestors
GET /v1/firms/mtngp.com/news